24HourWire

24HourWire

News from all angles

MedPage Today Center

Injectable Nanobody Wins FDA Approval for Myasthenia Gravis

(MedPage Today) -- The FDA on Friday approved injectable gefurulimab (Klygefa), a dual-binding nanobody that blocks complement component 5 (C5) activation, to treat generalized myasthenia gravis in a…

Redirecting to MedPage Today in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network